These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33819474)

  • 1. Ticagrelor or Aspirin After Coronary Artery Bypass in Patients With Chronic Kidney Disease.
    Sandner SE; Schunkert H; Kastrati A; Milojevic M; Böning A; Zimpfer D; Zellmer S; Wiedemann D; Laufer G; von Scheidt M;
    Ann Thorac Surg; 2022 Feb; 113(2):554-562. PubMed ID: 33819474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial.
    Gao C; Tomaniak M; Takahashi K; Kawashima H; Wang R; Hara H; Ono M; Montalescot G; Garg S; Haude M; Slagboom T; Vranckx P; Valgimigli M; Windecker S; van Geuns RJ; Hamm C; Steg PG; Onuma Y; Angiolillo DJ; Serruys PW
    Cardiovasc Diabetol; 2020 Oct; 19(1):179. PubMed ID: 33066794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial.
    Schunkert H; Boening A; von Scheidt M; Lanig C; Gusmini F; de Waha A; Kuna C; Fach A; Grothusen C; Oberhoffer M; Knosalla C; Walther T; Danner BC; Misfeld M; Zeymer U; Wimmer-Greinecker G; Siepe M; Grubitzsch H; Joost A; Schaefer A; Conradi L; Cremer J; Hamm C; Lange R; Radke PW; Schulz R; Laufer G; Grieshaber P; Pader P; Attmann T; Schmoeckel M; Meyer A; Ziegelhöffer T; Hambrecht R; Kastrati A; Sandner SE
    Eur Heart J; 2019 Aug; 40(29):2432-2440. PubMed ID: 31145798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial.
    de Waha A; Sandner S; von Scheidt M; Boening A; Koch-Buettner K; Hammel D; Hambrecht R; Danner BC; Schöndube FA; Goerlach G; Fischlein T; Schmoeckel M; Oberhoffer M; Schulz R; Walther T; Ziegelhöffer T; Knosalla C; Schönrath F; Beyersdorf F; Siepe M; Attmann T; Misfeld M; Mohr FW; Sievers HH; Joost A; Putman LM; Laufer G; Hamm C; Zeymer U; Kastrati A; Radke PW; Lange R; Cremer J; Schunkert H
    Am Heart J; 2016 Sep; 179():69-76. PubMed ID: 27595681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
    Steg PG; Bhatt DL; Simon T; Fox K; Mehta SR; Harrington RA; Held C; Andersson M; Himmelmann A; Ridderstråle W; Leonsson-Zachrisson M; Liu Y; Opolski G; Zateyshchikov D; Ge J; Nicolau JC; Corbalán R; Cornel JH; Widimský P; Leiter LA;
    N Engl J Med; 2019 Oct; 381(14):1309-1320. PubMed ID: 31475798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor monotherapy versus aspirin in patients undergoing multiple arterial or single arterial coronary artery bypass grafting: insights from the TiCAB trial.
    Sandner SE; Schunkert H; Kastrati A; Wiedemann D; Misfeld M; Böning A; Tebbe U; Nowak B; Stritzke J; Laufer G; von Scheidt M;
    Eur J Cardiothorac Surg; 2020 Apr; 57(4):732-739. PubMed ID: 31750899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
    Bhatt DL; Steg PG; Mehta SR; Leiter LA; Simon T; Fox K; Held C; Andersson M; Himmelmann A; Ridderstråle W; Chen J; Song Y; Diaz R; Goto S; James SK; Ray KK; Parkhomenko AN; Kosiborod MN; McGuire DK; Harrington RA;
    Lancet; 2019 Sep; 394(10204):1169-1180. PubMed ID: 31484629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study.
    Yan H; Tiemuerniyazi X; Song Y; Xu F; Feng W
    J Cardiothorac Surg; 2020 Jun; 15(1):155. PubMed ID: 32600365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
    Sandner S; Redfors B; Angiolillo DJ; Audisio K; Fremes SE; Janssen PWA; Kulik A; Mehran R; Peper J; Ruel M; Saw J; Soletti GJ; Starovoytov A; Ten Berg JM; Willemsen LM; Zhao Q; Zhu Y; Gaudino M
    JAMA; 2022 Aug; 328(6):554-562. PubMed ID: 35943473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.
    Vogel B; Baber U; Cohen DJ; Sartori S; Sharma SK; Angiolillo DJ; Farhan S; Goel R; Zhang Z; Briguori C; Collier T; Dangas G; Dudek D; Escaned J; Gil R; Han YL; Kaul U; Kornowski R; Krucoff MW; Kunadian V; Mehta SR; Moliterno D; Ohman EM; Sardella G; Witzenbichler B; Gibson CM; Pocock S; Huber K; Mehran R
    JAMA Cardiol; 2021 Sep; 6(9):1032-1041. PubMed ID: 33991416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
    Stefanini GG; Briguori C; Cao D; Baber U; Sartori S; Zhang Z; Dangas G; Angiolillo DJ; Mehta S; Cohen DJ; Collier T; Dudek D; Escaned J; Gibson CM; Gil R; Huber K; Kaul U; Kornowski R; Krucoff MW; Kunadian V; Moliterno DJ; Ohman EM; Oldroyd KG; Sardella G; Sharma SK; Shlofmitz R; Weisz G; Witzenbichler B; Pocock S; Mehran R
    Eur Heart J; 2021 Dec; 42(45):4683-4693. PubMed ID: 34423374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences among patients receiving ticagrelor monotherapy or aspirin after coronary bypass surgery: A prespecified subgroup analysis of the TiCAB trial.
    Sandner S; Kastrati A; Niessner A; Böning A; Zeymer U; Conradi L; Danner B; Zimpfer D; Färber G; Manville E; Schunkert H; von Scheidt M;
    Int J Cardiol; 2023 Jan; 370():129-135. PubMed ID: 36328115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial.
    Zhu Y; Zhang W; Dimagli A; Han L; Cheng Z; Mei J; Chen X; Wang X; Zhou Y; Xue Q; Hu J; Tang M; Wang R; Song Y; Kang L; Redfors B; Gaudino M; Zhao Q
    BMJ; 2024 Jun; 385():e075707. PubMed ID: 38862179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study.
    Sardella G; Beerkens FJ; Dangas G; Cao D; Baber U; Sartori S; Cohen DJ; Briguori C; Gil R; Nicolas J; Zhang Z; Dudek D; Kunadian V; Kornowski R; Weisz G; Claessen B; Marx S; Escaned J; Huber K; Collier T; Moliterno DJ; Ohman EM; Krucoff MW; Kastrati A; Steg PG; Angiolillo DJ; Mehta S; Shlofmitz R; Sharma S; Pocock S; Gibson CM; Mehran R
    EuroIntervention; 2022 Dec; 18(11):e897-e909. PubMed ID: 35979636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting.
    Zhu J; Zhu Y; Zhang M; Xue Q; Hu J; Liu H; Wang R; Wang X; Zhao Q
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):1030-1039.e4. PubMed ID: 32359899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
    Giustino G; Mehran R; Serruys PW; Sabik JF; Milojevic M; Simonton CA; Puskas JD; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Généreux P; Zhang Z; McAndrew T; Redfors B; Ragosta M; Kron IL; Dressler O; Leon MB; Pocock SJ; Ben-Yehuda O; Kappetein AP; Stone GW
    J Am Coll Cardiol; 2018 Aug; 72(7):754-765. PubMed ID: 30092952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial.
    Sandner S; Gaudino M; Redfors B; Angiolillo DJ; Ben-Yehuda O; Bhatt DL; Fremes SE; Lamy A; Marano R; Mehran R; Pocock S; Rao SV; Spertus JA; Weinsaft JW; Wells G; Ruel M
    EuroIntervention; 2024 Mar; 20(5):e322-e328. PubMed ID: 38436365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.
    Tomaniak M; Chichareon P; Klimczak-Tomaniak D; Takahashi K; Kogame N; Modolo R; Wang R; Ono M; Hara H; Gao C; Kawashima H; Rademaker-Havinga T; Garg S; Curzen N; Haude M; Kochman J; Gori T; Montalescot G; Angiolillo DJ; Capodanno D; Storey RF; Hamm C; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW; Anderson R
    Clin Res Cardiol; 2020 Jul; 109(7):930-943. PubMed ID: 31925529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery.
    Saw J; Wong GC; Mayo J; Bernstein V; Mancini GB; Ye J; Skarsgard P; Starovoytov A; Cairns J
    Heart; 2016 May; 102(10):763-9. PubMed ID: 26891756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.